Sinopharm Group Co Ltd - ESG Rating & Company Profile powered by AI
This Disclosure score covers 17 United Nations SDGs including: 'Quality Education', 'Reduced Inequalities' and 'Partnerships for the Goals'. Complete Sustainability assessment of Sinopharm Group Co Ltd are reached by registering for free. Check the bottom of the page for potential risks for Sinopharm Group Co Ltd based on sector, location and marketcap.
Sinopharm Group Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 7.2; made up of an environmental score of 8.0, social score of 6.9 and governance score of 6.7.
7.2
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 191 | Wockhardt Ltd | 7.3 | High |
| 191 | Zealand Pharma A/S | 7.3 | High |
| 217 | Sinopharm Group Co Ltd | 7.2 | High |
| 217 | Eurofins Scientific SE | 7.2 | High |
| 217 | Dermapharm Holding SE | 7.2 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Sinopharm Group Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Sinopharm Group Co Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes Sinopharm Group Co Ltd report the average age of the workforce?
Sign up for free to unlockDoes Sinopharm Group Co Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Sinopharm Group Co Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes Sinopharm Group Co Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes Sinopharm Group Co Ltd offer flexible work?
Sign up for free to unlockDoes Sinopharm Group Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Sinopharm Group Co Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Sinopharm Group Co Ltd conduct supply chain audits?
Sign up for free to unlockDoes Sinopharm Group Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Sinopharm Group Co Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes Sinopharm Group Co Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes Sinopharm Group Co Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Sinopharm Group Co Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Sinopharm Group Co Ltd disclose water use targets?
Sign up for free to unlockDoes Sinopharm Group Co Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid Sinopharm Group Co Ltd have a product recall in the last two years?
Sign up for free to unlockDoes Sinopharm Group Co Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes Sinopharm Group Co Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Sinopharm Group Co Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Sinopharm Group Co Ltd disclose parental leave metrics?
Sign up for free to unlockDoes Sinopharm Group Co Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Sinopharm Group Co Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Sinopharm Group Co Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes Sinopharm Group Co Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Sinopharm Group Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Sinopharm Group Co Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Sinopharm Group Co Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes Sinopharm Group Co Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Sinopharm Group Co Ltd disclose its waste policy?
Sign up for free to unlockDoes Sinopharm Group Co Ltd report according to TCFD requirements?
Sign up for free to unlockDoes Sinopharm Group Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Sinopharm Group Co Ltd disclose energy use targets?
Sign up for free to unlockDoes Sinopharm Group Co Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Sinopharm Group Co Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Sinopharm Group Co Ltd
These potential risks are based on the size, segment and geographies of the company.
Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail drug stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. As of December 31, 2021, this segment had 10,259 retail pharmacies. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology development and medicine consultation, investment, goods and technology import and export, business consultation, health consultation, medical consultation, market information consultation and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. Sinopharm Group Co. Ltd. has a strategic partnership with I-Mab to enhance its commercial capabilities and commercialization transformation. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.